Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer

Sofia Asioli, Francesca Maletta, Ludovica Verdun Di Cantogno, Maria A. Satolli, Marina Schena, Carla Pecchioni, Cristina Botta, Luigi Chiusa, Luca Molinaro, Luca Conti, Giuseppe Viale, Giuseppe Ingravallo, Eugenio Maiorano, Anna Sapino

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Gastric cancer shows intratumoral heterogeneity for human epidermal growth factor receptor 2 expression. We evaluated whether the number of tissue blocks analyzed or the antibodies used may influence the immunohistochemical results in gastrectomy specimens. Clinicopathologic data from 148 patients receiving gastric surgery for cancer were collected. One tissue block for each of 88 primary tumors and 60 paired primary tumors and metastases was examined for human epidermal growth factor receptor 2 status by immunohistochemistry using 3 different antibodies (HercepTest, CB11, and 4B5) and by fluorescent in situ hybridization. Two additional tissue blocks of the primary tumor were tested by immunohistochemistry if the results were negative on the first tissue block. The concordance among the 3 antibodies was 94.5% (testing 1 tissue block). Two cases showed a clinically significant discrepancy between primary tumor (score 0) and lymph nodes metastases (score 3+). Additional block analysis increased both the sensitivity (from 63% to 83%) and the accuracy (from 91% to 94%) of immunohistochemistry as compared with fluorescent in situ hybridization. The multiblock approach could potentially identify a greater number of human epidermal growth factor receptor 2-positive gastric cancers, particularly those with higher levels of intratumor heterogeneity. In turn, human epidermal growth factor receptor 2 positivity correlated with a worse prognosis (P =.011) and was an independent variable in multivariate analysis (hazard ratio, 1.57). In conclusion, testing more than 1 tissue block of cancer from specimens of gastric resection provides a more reliable human epidermal growth factor receptor 2 assessment regardless of the antibody used.

Original languageEnglish
Pages (from-to)2070-2079
Number of pages10
JournalHuman Pathology
Volume43
Issue number11
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Stomach Neoplasms
Antibodies
Immunohistochemistry
Fluorescence In Situ Hybridization
Neoplasms
Neoplasm Metastasis
Gastrectomy
human ERBB2 protein
Multivariate Analysis
Lymph Nodes

Keywords

  • Gastric cancer
  • HER2
  • Immunohistochemistry
  • Surgical specimen

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. / Asioli, Sofia; Maletta, Francesca; Verdun Di Cantogno, Ludovica; Satolli, Maria A.; Schena, Marina; Pecchioni, Carla; Botta, Cristina; Chiusa, Luigi; Molinaro, Luca; Conti, Luca; Viale, Giuseppe; Ingravallo, Giuseppe; Maiorano, Eugenio; Sapino, Anna.

In: Human Pathology, Vol. 43, No. 11, 11.2012, p. 2070-2079.

Research output: Contribution to journalArticle

Asioli, S, Maletta, F, Verdun Di Cantogno, L, Satolli, MA, Schena, M, Pecchioni, C, Botta, C, Chiusa, L, Molinaro, L, Conti, L, Viale, G, Ingravallo, G, Maiorano, E & Sapino, A 2012, 'Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer', Human Pathology, vol. 43, no. 11, pp. 2070-2079. https://doi.org/10.1016/j.humpath.2012.02.017
Asioli S, Maletta F, Verdun Di Cantogno L, Satolli MA, Schena M, Pecchioni C et al. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. Human Pathology. 2012 Nov;43(11):2070-2079. https://doi.org/10.1016/j.humpath.2012.02.017
Asioli, Sofia ; Maletta, Francesca ; Verdun Di Cantogno, Ludovica ; Satolli, Maria A. ; Schena, Marina ; Pecchioni, Carla ; Botta, Cristina ; Chiusa, Luigi ; Molinaro, Luca ; Conti, Luca ; Viale, Giuseppe ; Ingravallo, Giuseppe ; Maiorano, Eugenio ; Sapino, Anna. / Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. In: Human Pathology. 2012 ; Vol. 43, No. 11. pp. 2070-2079.
@article{e0262f12ec9b4aa9918634ae54f32c54,
title = "Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer",
abstract = "Gastric cancer shows intratumoral heterogeneity for human epidermal growth factor receptor 2 expression. We evaluated whether the number of tissue blocks analyzed or the antibodies used may influence the immunohistochemical results in gastrectomy specimens. Clinicopathologic data from 148 patients receiving gastric surgery for cancer were collected. One tissue block for each of 88 primary tumors and 60 paired primary tumors and metastases was examined for human epidermal growth factor receptor 2 status by immunohistochemistry using 3 different antibodies (HercepTest, CB11, and 4B5) and by fluorescent in situ hybridization. Two additional tissue blocks of the primary tumor were tested by immunohistochemistry if the results were negative on the first tissue block. The concordance among the 3 antibodies was 94.5{\%} (testing 1 tissue block). Two cases showed a clinically significant discrepancy between primary tumor (score 0) and lymph nodes metastases (score 3+). Additional block analysis increased both the sensitivity (from 63{\%} to 83{\%}) and the accuracy (from 91{\%} to 94{\%}) of immunohistochemistry as compared with fluorescent in situ hybridization. The multiblock approach could potentially identify a greater number of human epidermal growth factor receptor 2-positive gastric cancers, particularly those with higher levels of intratumor heterogeneity. In turn, human epidermal growth factor receptor 2 positivity correlated with a worse prognosis (P =.011) and was an independent variable in multivariate analysis (hazard ratio, 1.57). In conclusion, testing more than 1 tissue block of cancer from specimens of gastric resection provides a more reliable human epidermal growth factor receptor 2 assessment regardless of the antibody used.",
keywords = "Gastric cancer, HER2, Immunohistochemistry, Surgical specimen",
author = "Sofia Asioli and Francesca Maletta and {Verdun Di Cantogno}, Ludovica and Satolli, {Maria A.} and Marina Schena and Carla Pecchioni and Cristina Botta and Luigi Chiusa and Luca Molinaro and Luca Conti and Giuseppe Viale and Giuseppe Ingravallo and Eugenio Maiorano and Anna Sapino",
year = "2012",
month = "11",
doi = "10.1016/j.humpath.2012.02.017",
language = "English",
volume = "43",
pages = "2070--2079",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer

AU - Asioli, Sofia

AU - Maletta, Francesca

AU - Verdun Di Cantogno, Ludovica

AU - Satolli, Maria A.

AU - Schena, Marina

AU - Pecchioni, Carla

AU - Botta, Cristina

AU - Chiusa, Luigi

AU - Molinaro, Luca

AU - Conti, Luca

AU - Viale, Giuseppe

AU - Ingravallo, Giuseppe

AU - Maiorano, Eugenio

AU - Sapino, Anna

PY - 2012/11

Y1 - 2012/11

N2 - Gastric cancer shows intratumoral heterogeneity for human epidermal growth factor receptor 2 expression. We evaluated whether the number of tissue blocks analyzed or the antibodies used may influence the immunohistochemical results in gastrectomy specimens. Clinicopathologic data from 148 patients receiving gastric surgery for cancer were collected. One tissue block for each of 88 primary tumors and 60 paired primary tumors and metastases was examined for human epidermal growth factor receptor 2 status by immunohistochemistry using 3 different antibodies (HercepTest, CB11, and 4B5) and by fluorescent in situ hybridization. Two additional tissue blocks of the primary tumor were tested by immunohistochemistry if the results were negative on the first tissue block. The concordance among the 3 antibodies was 94.5% (testing 1 tissue block). Two cases showed a clinically significant discrepancy between primary tumor (score 0) and lymph nodes metastases (score 3+). Additional block analysis increased both the sensitivity (from 63% to 83%) and the accuracy (from 91% to 94%) of immunohistochemistry as compared with fluorescent in situ hybridization. The multiblock approach could potentially identify a greater number of human epidermal growth factor receptor 2-positive gastric cancers, particularly those with higher levels of intratumor heterogeneity. In turn, human epidermal growth factor receptor 2 positivity correlated with a worse prognosis (P =.011) and was an independent variable in multivariate analysis (hazard ratio, 1.57). In conclusion, testing more than 1 tissue block of cancer from specimens of gastric resection provides a more reliable human epidermal growth factor receptor 2 assessment regardless of the antibody used.

AB - Gastric cancer shows intratumoral heterogeneity for human epidermal growth factor receptor 2 expression. We evaluated whether the number of tissue blocks analyzed or the antibodies used may influence the immunohistochemical results in gastrectomy specimens. Clinicopathologic data from 148 patients receiving gastric surgery for cancer were collected. One tissue block for each of 88 primary tumors and 60 paired primary tumors and metastases was examined for human epidermal growth factor receptor 2 status by immunohistochemistry using 3 different antibodies (HercepTest, CB11, and 4B5) and by fluorescent in situ hybridization. Two additional tissue blocks of the primary tumor were tested by immunohistochemistry if the results were negative on the first tissue block. The concordance among the 3 antibodies was 94.5% (testing 1 tissue block). Two cases showed a clinically significant discrepancy between primary tumor (score 0) and lymph nodes metastases (score 3+). Additional block analysis increased both the sensitivity (from 63% to 83%) and the accuracy (from 91% to 94%) of immunohistochemistry as compared with fluorescent in situ hybridization. The multiblock approach could potentially identify a greater number of human epidermal growth factor receptor 2-positive gastric cancers, particularly those with higher levels of intratumor heterogeneity. In turn, human epidermal growth factor receptor 2 positivity correlated with a worse prognosis (P =.011) and was an independent variable in multivariate analysis (hazard ratio, 1.57). In conclusion, testing more than 1 tissue block of cancer from specimens of gastric resection provides a more reliable human epidermal growth factor receptor 2 assessment regardless of the antibody used.

KW - Gastric cancer

KW - HER2

KW - Immunohistochemistry

KW - Surgical specimen

UR - http://www.scopus.com/inward/record.url?scp=84867848639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867848639&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2012.02.017

DO - 10.1016/j.humpath.2012.02.017

M3 - Article

VL - 43

SP - 2070

EP - 2079

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 11

ER -